Article Details

Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy - Seeking Alpha

Retrieved on: 2023-01-09 19:48:22

Tags for this article:

Click the tags to see associated articles and topics

Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy - Seeking Alpha. View article details on hiswai:

Excerpt

The companies noted that neutropenia events were manageable with dose reductions for palbociclib. Due to the recent data analysis, the companies plan ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up